Biomarker panel for early screening of trastuzumab -induced cardiotoxicity among breast cancer patients in west virginia.

Pillai SS, Pereira DG, Bonsu G, Chaudhry H, Puri N, Lakhani HV, Tirona MT, Sodhi K, Thompson E

DOI: 10.3389/fphar.2022.953178
Published: 2022
Container: Frontiers in pharmacology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2022.953178,
  title = {Biomarker panel for early screening of trastuzumab -induced cardiotoxicity among breast cancer patients in west virginia.},
  author = {Pillai SS and Pereira DG and Bonsu G and Chaudhry H and Puri N and Lakhani HV and Tirona MT and Sodhi K and Thompson E},
  year = {2022},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2022.953178},
  url = {https://doi.org/10.3389/fphar.2022.953178}
}

RIS

TY  - JOUR
TI  - Biomarker panel for early screening of trastuzumab -induced cardiotoxicity among breast cancer patients in west virginia.
AU  - Pillai SS
AU  - Pereira DG
AU  - Bonsu G
AU  - Chaudhry H
AU  - Puri N
AU  - Lakhani HV
AU  - Tirona MT
AU  - Sodhi K
AU  - Thompson E
PY  - 2022
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2022.953178
UR  - https://doi.org/10.3389/fphar.2022.953178
ER  -

APA

SS, P., DG, P., G, B., H, C., N, P., HV, L., MT, T., K, S., & E, T. (2022). Biomarker panel for early screening of trastuzumab -induced cardiotoxicity among breast cancer patients in west virginia.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2022.953178

Source records

pubmed · retrieved 2026-09-24T20:45:35.953Z